Casandra
Casandra Test Code PG93804Version 1 (DRAFT)
Performing Lab
Comprehensive Arrhythmia and Cardiomyopathy Panel
Clinical Use
Order TestUse
This test is for individuals with relevant features who have a clinical or suspected diagnosis of cardiac arrhythmia and/or cardiomyopathy. It is also for individuals with unexplained sudden cardiac death/arrest and individuals with a family history suggestive of cardiac arrhythmia and/or cardiomyopathy.
Special Instructions
Not provided.
Limitations
The tests have not been cleared or approved by the US Food and Drug Administration. The performance characteristics of the tests were validated by PreventionGenetics LLC under CAP and CLIA regulations, but specific limitations or sensitivity parameters are not provided.
Test Details
New York Approved
Methodology
NGS (CGP)
Biomarkers
NGS with CNV Analysis • CGP
Result Turnaround Time
14-21 days
Related Documents
For more information, please review the documents below
Specimen Requirements
Specimen
Whole Blood
Volume
Not provided
Minimum Volume
Not provided